�ݺ�ߣshows by User: theheartorg

�ݺ�ߣshows by User: theheartorg / http://www.slideshare.net/images/logo.gif �ݺ�ߣshows by User: theheartorg / Fri, 07 Dec 2012 06:59:11 GMT �ݺ�ߣShare feed for �ݺ�ߣshows by User: theheartorg TCT 2012 research highlights: A slideshow presentation /slideshow/tct-2012-research-highlights-a-slideshow-presentation/15534342 tct2012-121207065911-phpapp02
TCT 2012 took place in Miami, FL, on October 22-26. Key trials and presentations at the sessions included: PFO Closure, RESPECT, PC Trial, FAME II, ADVANCE, TAVR, TRILOGY-ACS, Live cases, DESSOLVE I and II, SES PARTNER B, MASTER, Career Achievement Award, ADAPT-DES, STEMI-RADIAL and POST]]>
TCT 2012 took place in Miami, FL, on October 22-26. Key trials and presentations at the sessions included: PFO Closure, RESPECT, PC Trial, FAME II, ADVANCE, TAVR, TRILOGY-ACS, Live cases, DESSOLVE I and II, SES PARTNER B, MASTER, Career Achievement Award, ADAPT-DES, STEMI-RADIAL and POST]]> Fri, 07 Dec 2012 06:59:11 GMT /slideshow/tct-2012-research-highlights-a-slideshow-presentation/15534342 theheartorg@slideshare.net(theheartorg) TCT 2012 research highlights: A slideshow presentation theheartorg TCT 2012 took place in Miami, FL, on October 22-26. Key trials and presentations at the sessions included: PFO Closure, RESPECT, PC Trial, FAME II, ADVANCE, TAVR, TRILOGY-ACS, Live cases, DESSOLVE I and II, SES PARTNER B, MASTER, Career Achievement Award, ADAPT-DES, STEMI-RADIAL and POST <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/tct2012-121207065911-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds" /> TCT 2012 took place in Miami, FL, on October 22-26. Key trials and presentations at the sessions included: PFO Closure, RESPECT, PC Trial, FAME II, ADVANCE, TAVR, TRILOGY-ACS, Live cases, DESSOLVE I and II, SES PARTNER B, MASTER, Career Achievement Award, ADAPT-DES, STEMI-RADIAL and POST

TCT 2012 research highlights: A slideshow presentation from theheart.org

]]> 3360 6 https://cdn.slidesharecdn.com/ss_thumbnails/tct2012-121207065911-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation White http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

1 ESC 2012 research highlights: A slideshow presentation /slideshow/esc-2012-research-highlights-a-slideshow-presentation/15534250 esc2012-121207065209-phpapp02
The European Society of Cardiology (ESC) 2012 Congress took place in Munich, Germany from August 25 through August 29, 2012. Key trials presented at the sessions include: WOEST, ALTITUDE, FAME II, TRILOGY ACS, ACCESS EU,PURE, GARY. IABP SHOCK II, PARAMOUNT and DeFACTO]]>
The European Society of Cardiology (ESC) 2012 Congress took place in Munich, Germany from August 25 through August 29, 2012. Key trials presented at the sessions include: WOEST, ALTITUDE, FAME II, TRILOGY ACS, ACCESS EU,PURE, GARY. IABP SHOCK II, PARAMOUNT and DeFACTO]]> Fri, 07 Dec 2012 06:52:09 GMT /slideshow/esc-2012-research-highlights-a-slideshow-presentation/15534250 theheartorg@slideshare.net(theheartorg) ESC 2012 research highlights: A slideshow presentation theheartorg The European Society of Cardiology (ESC) 2012 Congress took place in Munich, Germany from August 25 through August 29, 2012. Key trials presented at the sessions include: WOEST, ALTITUDE, FAME II, TRILOGY ACS, ACCESS EU,PURE, GARY. IABP SHOCK II, PARAMOUNT and DeFACTO <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/esc2012-121207065209-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds" /> The European Society of Cardiology (ESC) 2012 Congress took place in Munich, Germany from August 25 through August 29, 2012. Key trials presented at the sessions include: WOEST, ALTITUDE, FAME II, TRILOGY ACS, ACCESS EU,PURE, GARY. IABP SHOCK II, PARAMOUNT and DeFACTO

ESC 2012 research highlights: A slideshow presentation from theheart.org

]]> 1935 5 https://cdn.slidesharecdn.com/ss_thumbnails/esc2012-121207065209-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation White http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

1 AHA 2012 Research Highlights /slideshow/aha-2012-research-highlights/15299237 aha2012-121122084556-phpapp01
The American Heart Association (AHA) 2012 Scientific Sessions took place in Los Angeles, CA on November 3-7, 2012. Key trials presented at the sessions include: FREEDOM, TACT, UMPIRE, PHS II, OPERA and FORWARD, ASPIRE, TRILOGY ACS/ARCTIC, MADIT-RIT, RELAX-AHF, POSEIDON / SCIPIO, PCSK9 studies, PCSK9, dal-OUTCOMES andLoDoCo.]]>
The American Heart Association (AHA) 2012 Scientific Sessions took place in Los Angeles, CA on November 3-7, 2012. Key trials presented at the sessions include: FREEDOM, TACT, UMPIRE, PHS II, OPERA and FORWARD, ASPIRE, TRILOGY ACS/ARCTIC, MADIT-RIT, RELAX-AHF, POSEIDON / SCIPIO, PCSK9 studies, PCSK9, dal-OUTCOMES andLoDoCo.]]> Thu, 22 Nov 2012 08:45:55 GMT /slideshow/aha-2012-research-highlights/15299237 theheartorg@slideshare.net(theheartorg) AHA 2012 Research Highlights theheartorg The American Heart Association (AHA) 2012 Scientific Sessions took place in Los Angeles, CA on November 3-7, 2012. Key trials presented at the sessions include: FREEDOM, TACT, UMPIRE, PHS II, OPERA and FORWARD, ASPIRE, TRILOGY ACS/ARCTIC, MADIT-RIT, RELAX-AHF, POSEIDON / SCIPIO, PCSK9 studies, PCSK9, dal-OUTCOMES andLoDoCo. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/aha2012-121122084556-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds" /> The American Heart Association (AHA) 2012 Scientific Sessions took place in Los Angeles, CA on November 3-7, 2012. Key trials presented at the sessions include: FREEDOM, TACT, UMPIRE, PHS II, OPERA and FORWARD, ASPIRE, TRILOGY ACS/ARCTIC, MADIT-RIT, RELAX-AHF, POSEIDON / SCIPIO, PCSK9 studies, PCSK9, dal-OUTCOMES andLoDoCo.

AHA 2012 Research Highlights from theheart.org

]]> 1408 10 https://cdn.slidesharecdn.com/ss_thumbnails/aha2012-121122084556-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds presentation White http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

1 AHA 2010 research highlights: A slideshow presentation /slideshow/aha-2010-research-highlights-a-slideshow-presentation/13958821 aha2010-120813102654-phpapp02
http://www.theheart.org/editorial-program/1156073.do The American Heart Association (AHA) 2010 Scientific Sessions took place in Chicago. Key trials presented at the sessions include: ADVANCE,RAFT,QRS EMPHASIS-HF,ASCEND HF,ROCKET AF,CLOSURE I,GRAVITAS,P-OM3,BASKET-PROVE,DEFINE,SYMPLICITY HTN,ASCOT CRP and ACT. ]]>
http://www.theheart.org/editorial-program/1156073.do The American Heart Association (AHA) 2010 Scientific Sessions took place in Chicago. Key trials presented at the sessions include: ADVANCE,RAFT,QRS EMPHASIS-HF,ASCEND HF,ROCKET AF,CLOSURE I,GRAVITAS,P-OM3,BASKET-PROVE,DEFINE,SYMPLICITY HTN,ASCOT CRP and ACT. ]]> Mon, 13 Aug 2012 10:26:52 GMT /slideshow/aha-2010-research-highlights-a-slideshow-presentation/13958821 theheartorg@slideshare.net(theheartorg) AHA 2010 research highlights: A slideshow presentation theheartorg http://www.theheart.org/editorial-program/1156073.do The American Heart Association (AHA) 2010 Scientific Sessions took place in Chicago. Key trials presented at the sessions include: ADVANCE,RAFT,QRS EMPHASIS-HF,ASCEND HF,ROCKET AF,CLOSURE I,GRAVITAS,P-OM3,BASKET-PROVE,DEFINE,SYMPLICITY HTN,ASCOT CRP and ACT. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/aha2010-120813102654-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds" /> http://www.theheart.org/editorial-program/1156073.do The American Heart Association (AHA) 2010 Scientific Sessions took place in Chicago. Key trials presented at the sessions include: ADVANCE,RAFT,QRS EMPHASIS-HF,ASCEND HF,ROCKET AF,CLOSURE I,GRAVITAS,P-OM3,BASKET-PROVE,DEFINE,SYMPLICITY HTN,ASCOT CRP and ACT.

AHA 2010 research highlights: A slideshow presentation from theheart.org

]]> 1279 5 https://cdn.slidesharecdn.com/ss_thumbnails/aha2010-120813102654-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation White http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

1 TCT 2010 research highlights: A slideshow presentation /slideshow/tct-2010-research-highlights-a-slideshow-presentation/13958772 tct2010-120813102211-phpapp01
http://www.theheart.org/editorial-program/1128553.do The 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium took place in Washington. Key trials presented at the meeting include: PARTNER, ZILVER PTX, ISAR-TEST 4,SORT-OUT 4, COMPARE,SPIRIT IV, HORIZONS-AMI, BIOFREEDOM, PROTECT-AF, CAP and Robotically assisted PCI ]]>
http://www.theheart.org/editorial-program/1128553.do The 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium took place in Washington. Key trials presented at the meeting include: PARTNER, ZILVER PTX, ISAR-TEST 4,SORT-OUT 4, COMPARE,SPIRIT IV, HORIZONS-AMI, BIOFREEDOM, PROTECT-AF, CAP and Robotically assisted PCI ]]> Mon, 13 Aug 2012 10:22:09 GMT /slideshow/tct-2010-research-highlights-a-slideshow-presentation/13958772 theheartorg@slideshare.net(theheartorg) TCT 2010 research highlights: A slideshow presentation theheartorg http://www.theheart.org/editorial-program/1128553.do The 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium took place in Washington. Key trials presented at the meeting include: PARTNER, ZILVER PTX, ISAR-TEST 4,SORT-OUT 4, COMPARE,SPIRIT IV, HORIZONS-AMI, BIOFREEDOM, PROTECT-AF, CAP and Robotically assisted PCI <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/tct2010-120813102211-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds" /> http://www.theheart.org/editorial-program/1128553.do The 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium took place in Washington. Key trials presented at the meeting include: PARTNER, ZILVER PTX, ISAR-TEST 4,SORT-OUT 4, COMPARE,SPIRIT IV, HORIZONS-AMI, BIOFREEDOM, PROTECT-AF, CAP and Robotically assisted PCI

TCT 2010 research highlights: A slideshow presentation from theheart.org

]]> 905 5 https://cdn.slidesharecdn.com/ss_thumbnails/tct2010-120813102211-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds presentation White http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

1 ESC 2010 Research Highlights : A slideshow presentation /slideshow/esc-2010-research-highlights/13958705 esc2010-120813101327-phpapp02
http://www.theheart.org/editorial-program/1119685.do Key trials presented at the meeting include: AVERROES, SHIFT, ALPHA OMEGA Trial, EINSTEIN DVT, FUTURA OASIS-8, LESSON 1, PLATO genetic substudies,CURE/ACTIVE A, INNOVATE PCI, ATOLL, COPPS, RESPONSE and STAR-HEART ]]>
http://www.theheart.org/editorial-program/1119685.do Key trials presented at the meeting include: AVERROES, SHIFT, ALPHA OMEGA Trial, EINSTEIN DVT, FUTURA OASIS-8, LESSON 1, PLATO genetic substudies,CURE/ACTIVE A, INNOVATE PCI, ATOLL, COPPS, RESPONSE and STAR-HEART ]]> Mon, 13 Aug 2012 10:13:26 GMT /slideshow/esc-2010-research-highlights/13958705 theheartorg@slideshare.net(theheartorg) ESC 2010 Research Highlights : A slideshow presentation theheartorg http://www.theheart.org/editorial-program/1119685.do Key trials presented at the meeting include: AVERROES, SHIFT, ALPHA OMEGA Trial, EINSTEIN DVT, FUTURA OASIS-8, LESSON 1, PLATO genetic substudies,CURE/ACTIVE A, INNOVATE PCI, ATOLL, COPPS, RESPONSE and STAR-HEART <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/esc2010-120813101327-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds" /> http://www.theheart.org/editorial-program/1119685.do Key trials presented at the meeting include: AVERROES, SHIFT, ALPHA OMEGA Trial, EINSTEIN DVT, FUTURA OASIS-8, LESSON 1, PLATO genetic substudies,CURE/ACTIVE A, INNOVATE PCI, ATOLL, COPPS, RESPONSE and STAR-HEART

ESC 2010 Research Highlights : A slideshow presentation from theheart.org

]]> 974 6 https://cdn.slidesharecdn.com/ss_thumbnails/esc2010-120813101327-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation White http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

1 CHAMPION trial - Summary & Results /slideshow/champion-championpci-and-championplatform/13900921 championfinal-120807100438-phpapp02
A study with ACS patients scheduled for PCI on CHAMPION–PCI and CHAMPION–PLATFORM ]]>
A study with ACS patients scheduled for PCI on CHAMPION–PCI and CHAMPION–PLATFORM ]]> Tue, 07 Aug 2012 10:04:34 GMT /slideshow/champion-championpci-and-championplatform/13900921 theheartorg@slideshare.net(theheartorg) CHAMPION trial - Summary & Results theheartorg A study with ACS patients scheduled for PCI on CHAMPION–PCI and CHAMPION–PLATFORM <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/championfinal-120807100438-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds" /> A study with ACS patients scheduled for PCI on CHAMPION–PCI and CHAMPION–PLATFORM

CHAMPION trial - Summary & Results from theheart.org

]]> 1475 5 https://cdn.slidesharecdn.com/ss_thumbnails/championfinal-120807100438-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation White http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

1 ONTARGET trial - Summary & Results with Ramipril Global Endpoint /slideshow/ontarget-ongoing-telmisartan-alone-and-in-combination-with-ramipril-global-endpoint-trial/13900914 ontargetfinal-120807100352-phpapp02
A study to test whether an ARB (which blocks the effects of angiotensin II without enhancing bradykinin) was similarly effective to an ACE inhibitor and whether the combination of an ACE inhibitor and an ARB may be superior ]]>
A study to test whether an ARB (which blocks the effects of angiotensin II without enhancing bradykinin) was similarly effective to an ACE inhibitor and whether the combination of an ACE inhibitor and an ARB may be superior ]]> Tue, 07 Aug 2012 10:03:50 GMT /slideshow/ontarget-ongoing-telmisartan-alone-and-in-combination-with-ramipril-global-endpoint-trial/13900914 theheartorg@slideshare.net(theheartorg) ONTARGET trial - Summary & Results with Ramipril Global Endpoint theheartorg A study to test whether an ARB (which blocks the effects of angiotensin II without enhancing bradykinin) was similarly effective to an ACE inhibitor and whether the combination of an ACE inhibitor and an ARB may be superior <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ontargetfinal-120807100352-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds" /> A study to test whether an ARB (which blocks the effects of angiotensin II without enhancing bradykinin) was similarly effective to an ACE inhibitor and whether the combination of an ACE inhibitor and an ARB may be superior

ONTARGET trial - Summary & Results with Ramipril Global Endpoint from theheart.org

]]> 4014 9 https://cdn.slidesharecdn.com/ss_thumbnails/ontargetfinal-120807100352-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation White http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

1 OASIS-6 trial - Summary & Results at ACC /slideshow/oasis6-sixth-organization-to-assess-strategies-in-acute-ischemic-syndromes/13900877 oasis6final-120807095849-phpapp01
http://www.theheart.org/web_slides/1136801.do A randomized, placebo study using patients with STEMI exposed to fondaparinux or to usual care-placebo. The Sixth Organization to Assess Strategies in Acute Ischemic Syndromes.]]>
http://www.theheart.org/web_slides/1136801.do A randomized, placebo study using patients with STEMI exposed to fondaparinux or to usual care-placebo. The Sixth Organization to Assess Strategies in Acute Ischemic Syndromes.]]> Tue, 07 Aug 2012 09:58:47 GMT /slideshow/oasis6-sixth-organization-to-assess-strategies-in-acute-ischemic-syndromes/13900877 theheartorg@slideshare.net(theheartorg) OASIS-6 trial - Summary & Results at ACC theheartorg http://www.theheart.org/web_slides/1136801.do A randomized, placebo study using patients with STEMI exposed to fondaparinux or to usual care-placebo. The Sixth Organization to Assess Strategies in Acute Ischemic Syndromes. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/oasis6final-120807095849-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds" /> http://www.theheart.org/web_slides/1136801.do A randomized, placebo study using patients with STEMI exposed to fondaparinux or to usual care-placebo. The Sixth Organization to Assess Strategies in Acute Ischemic Syndromes.

OASIS-6 trial - Summary & Results at ACC from theheart.org

]]> 817 4 https://cdn.slidesharecdn.com/ss_thumbnails/oasis6final-120807095849-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds presentation White http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

1 IDEAL trial - Summary & Results /slideshow/ideal-incremental-decrease-in-endpoints-through-aggressive-lipid-lowering/13900865 idealfinal-120807095712-phpapp01
http://www.theheart.org/web_slides/1136565.do A prospective,randomized, open-label, blinded-end-point evaluation trial on incremental decrease in endpoints through aggressive lipid lowering (IDEAL) using patients with a history of acute MI]]>
http://www.theheart.org/web_slides/1136565.do A prospective,randomized, open-label, blinded-end-point evaluation trial on incremental decrease in endpoints through aggressive lipid lowering (IDEAL) using patients with a history of acute MI]]> Tue, 07 Aug 2012 09:57:11 GMT /slideshow/ideal-incremental-decrease-in-endpoints-through-aggressive-lipid-lowering/13900865 theheartorg@slideshare.net(theheartorg) IDEAL trial - Summary & Results theheartorg http://www.theheart.org/web_slides/1136565.do A prospective,randomized, open-label, blinded-end-point evaluation trial on incremental decrease in endpoints through aggressive lipid lowering (IDEAL) using patients with a history of acute MI <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/idealfinal-120807095712-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds" /> http://www.theheart.org/web_slides/1136565.do A prospective,randomized, open-label, blinded-end-point evaluation trial on incremental decrease in endpoints through aggressive lipid lowering (IDEAL) using patients with a history of acute MI

IDEAL trial - Summary & Results from theheart.org

]]> 655 2 https://cdn.slidesharecdn.com/ss_thumbnails/idealfinal-120807095712-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds presentation White http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

1 PURE trial - Summary & Results /slideshow/pure-prospective-urban-rural-epidemiology/13900824 purefinal-120807095231-phpapp01
http://www.theheart.org/web_slides/1283911.do A survey of 153,996 adults on prospective urban rural epidemiology (PURE) to examine the relationship of societal influences on human lifestyle behaviors, CV risk factors, and incidence of chronic non communicable diseases]]>
http://www.theheart.org/web_slides/1283911.do A survey of 153,996 adults on prospective urban rural epidemiology (PURE) to examine the relationship of societal influences on human lifestyle behaviors, CV risk factors, and incidence of chronic non communicable diseases]]> Tue, 07 Aug 2012 09:52:30 GMT /slideshow/pure-prospective-urban-rural-epidemiology/13900824 theheartorg@slideshare.net(theheartorg) PURE trial - Summary & Results theheartorg http://www.theheart.org/web_slides/1283911.do A survey of 153,996 adults on prospective urban rural epidemiology (PURE) to examine the relationship of societal influences on human lifestyle behaviors, CV risk factors, and incidence of chronic non communicable diseases <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/purefinal-120807095231-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds" /> http://www.theheart.org/web_slides/1283911.do A survey of 153,996 adults on prospective urban rural epidemiology (PURE) to examine the relationship of societal influences on human lifestyle behaviors, CV risk factors, and incidence of chronic non communicable diseases

PURE trial - Summary & Results from theheart.org

]]> 2442 4 https://cdn.slidesharecdn.com/ss_thumbnails/purefinal-120807095231-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds presentation White http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

1 ACCORD BP trial - Summary & Results /slideshow/accord-bp-action-to-control-cardiovascular-risk-in-diabetes-mdash-bloodpressurelowering-arm/13900787 accordbpfinal-120807094753-phpapp02
http://www.theheart.org/web_slides/1146197.do A randomized study,on action to control cardiovascular risk in diabetes and blood-pressure-lowering arm (ACCORD BP) in a nonblinded fashion, to intensive BP-lowering ]]>
http://www.theheart.org/web_slides/1146197.do A randomized study,on action to control cardiovascular risk in diabetes and blood-pressure-lowering arm (ACCORD BP) in a nonblinded fashion, to intensive BP-lowering ]]> Tue, 07 Aug 2012 09:47:52 GMT /slideshow/accord-bp-action-to-control-cardiovascular-risk-in-diabetes-mdash-bloodpressurelowering-arm/13900787 theheartorg@slideshare.net(theheartorg) ACCORD BP trial - Summary & Results theheartorg http://www.theheart.org/web_slides/1146197.do A randomized study,on action to control cardiovascular risk in diabetes and blood-pressure-lowering arm (ACCORD BP) in a nonblinded fashion, to intensive BP-lowering <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/accordbpfinal-120807094753-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds" /> http://www.theheart.org/web_slides/1146197.do A randomized study,on action to control cardiovascular risk in diabetes and blood-pressure-lowering arm (ACCORD BP) in a nonblinded fashion, to intensive BP-lowering

ACCORD BP trial - Summary & Results from theheart.org

]]> 2783 9 https://cdn.slidesharecdn.com/ss_thumbnails/accordbpfinal-120807094753-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation White http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

1 RIVAL trial - Summary & Results /slideshow/rival-radial-vs-femoral-access-for-coronary-intervention/13779616 rivalfinal-120727134634-phpapp02
http://www.theheart.org/web_slides/1215405.do A head-to-head comparison of Radial vs Femoral Access for Coronary Intervention (RIVAL)]]>
http://www.theheart.org/web_slides/1215405.do A head-to-head comparison of Radial vs Femoral Access for Coronary Intervention (RIVAL)]]> Fri, 27 Jul 2012 13:46:33 GMT /slideshow/rival-radial-vs-femoral-access-for-coronary-intervention/13779616 theheartorg@slideshare.net(theheartorg) RIVAL trial - Summary & Results theheartorg http://www.theheart.org/web_slides/1215405.do A head-to-head comparison of Radial vs Femoral Access for Coronary Intervention (RIVAL) <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/rivalfinal-120727134634-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds" /> http://www.theheart.org/web_slides/1215405.do A head-to-head comparison of Radial vs Femoral Access for Coronary Intervention (RIVAL)

RIVAL trial - Summary & Results from theheart.org

]]> 1186 2 https://cdn.slidesharecdn.com/ss_thumbnails/rivalfinal-120727134634-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation White http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

1 ACT trial - Summary & Results /slideshow/act-acetylcysteine-for-contrastinduced-nephropathy-trial/13779604 actfinal-120727134531-phpapp02
http://www.theheart.org/web_slides/1186083.do A randomized study on Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT) with patients undergoing an angiographic procedure.]]>
http://www.theheart.org/web_slides/1186083.do A randomized study on Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT) with patients undergoing an angiographic procedure.]]> Fri, 27 Jul 2012 13:45:31 GMT /slideshow/act-acetylcysteine-for-contrastinduced-nephropathy-trial/13779604 theheartorg@slideshare.net(theheartorg) ACT trial - Summary & Results theheartorg http://www.theheart.org/web_slides/1186083.do A randomized study on Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT) with patients undergoing an angiographic procedure. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/actfinal-120727134531-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds" /> http://www.theheart.org/web_slides/1186083.do A randomized study on Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT) with patients undergoing an angiographic procedure.

ACT trial - Summary & Results from theheart.org

]]> 803 4 https://cdn.slidesharecdn.com/ss_thumbnails/actfinal-120727134531-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation White http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

1 P-OM3 trial - Summary & Results /slideshow/pom3/13779560 pom3final-120727134013-phpapp02
http://www.theheart.org/web_slides/1171735.do One of the largest studies to examine the effect of omega-3 polyunsaturated fatty acids (PUFA) on AF ]]>
http://www.theheart.org/web_slides/1171735.do One of the largest studies to examine the effect of omega-3 polyunsaturated fatty acids (PUFA) on AF ]]> Fri, 27 Jul 2012 13:40:11 GMT /slideshow/pom3/13779560 theheartorg@slideshare.net(theheartorg) P-OM3 trial - Summary & Results theheartorg http://www.theheart.org/web_slides/1171735.do One of the largest studies to examine the effect of omega-3 polyunsaturated fatty acids (PUFA) on AF <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/pom3final-120727134013-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds" /> http://www.theheart.org/web_slides/1171735.do One of the largest studies to examine the effect of omega-3 polyunsaturated fatty acids (PUFA) on AF

P-OM3 trial - Summary & Results from theheart.org

]]> 338 2 https://cdn.slidesharecdn.com/ss_thumbnails/pom3final-120727134013-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation White http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

1 TRITON-TIMI 38 trial - Summary & Results /slideshow/tritontimi-38/13779548 tritontimi38final-120727133759-phpapp02
http://www.theheart.org/web_slides/1144191.do A randomized to prasugrel or clopidogrel study on TRITON-TIMI 38 with patients who have moderate- to high-risk ACS. ]]>
http://www.theheart.org/web_slides/1144191.do A randomized to prasugrel or clopidogrel study on TRITON-TIMI 38 with patients who have moderate- to high-risk ACS. ]]> Fri, 27 Jul 2012 13:37:57 GMT /slideshow/tritontimi-38/13779548 theheartorg@slideshare.net(theheartorg) TRITON-TIMI 38 trial - Summary & Results theheartorg http://www.theheart.org/web_slides/1144191.do A randomized to prasugrel or clopidogrel study on TRITON-TIMI 38 with patients who have moderate- to high-risk ACS. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/tritontimi38final-120727133759-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds" /> http://www.theheart.org/web_slides/1144191.do A randomized to prasugrel or clopidogrel study on TRITON-TIMI 38 with patients who have moderate- to high-risk ACS.

TRITON-TIMI 38 trial - Summary & Results from theheart.org

]]> 4933 6 https://cdn.slidesharecdn.com/ss_thumbnails/tritontimi38final-120727133759-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation White http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

1 SHIFT trial - Summary & Results /slideshow/shift-systolic-heart-failure-treatment-with-the-if-inhibitor-ivabradine-trial-13779535/13779535 shiftfinal-120727133613-phpapp02
http://www.theheart.org/web_slides/1425587.do A randomized to placebo or ivabradine study on Systolic Heart Failure Treatment with the If Inhibitor Ivabradine (SHIFT) with patients on standard HF medications according to guidelines]]>
http://www.theheart.org/web_slides/1425587.do A randomized to placebo or ivabradine study on Systolic Heart Failure Treatment with the If Inhibitor Ivabradine (SHIFT) with patients on standard HF medications according to guidelines]]> Fri, 27 Jul 2012 13:36:13 GMT /slideshow/shift-systolic-heart-failure-treatment-with-the-if-inhibitor-ivabradine-trial-13779535/13779535 theheartorg@slideshare.net(theheartorg) SHIFT trial - Summary & Results theheartorg http://www.theheart.org/web_slides/1425587.do A randomized to placebo or ivabradine study on Systolic Heart Failure Treatment with the If Inhibitor Ivabradine (SHIFT) with patients on standard HF medications according to guidelines <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/shiftfinal-120727133613-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds" /> http://www.theheart.org/web_slides/1425587.do A randomized to placebo or ivabradine study on Systolic Heart Failure Treatment with the If Inhibitor Ivabradine (SHIFT) with patients on standard HF medications according to guidelines

SHIFT trial - Summary & Results from theheart.org

]]> 3935 5 https://cdn.slidesharecdn.com/ss_thumbnails/shiftfinal-120727133613-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation White http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

1 PROTECT-AF trial - Summary & Results /slideshow/protectaf-embolic-protection-in-patients-with-atrial-fibrillation/13779523 protectaffinal-120727133352-phpapp02
http://www.theheart.org/web_slides/1146285.do A prospective randomized trial on Embolic Protection in Patients with Atrial Fibrillation (PROTECT-AF) comparing closure of the LAA* (with the Watchman occluder) with long-term warfarin therapy]]>
http://www.theheart.org/web_slides/1146285.do A prospective randomized trial on Embolic Protection in Patients with Atrial Fibrillation (PROTECT-AF) comparing closure of the LAA* (with the Watchman occluder) with long-term warfarin therapy]]> Fri, 27 Jul 2012 13:33:50 GMT /slideshow/protectaf-embolic-protection-in-patients-with-atrial-fibrillation/13779523 theheartorg@slideshare.net(theheartorg) PROTECT-AF trial - Summary & Results theheartorg http://www.theheart.org/web_slides/1146285.do A prospective randomized trial on Embolic Protection in Patients with Atrial Fibrillation (PROTECT-AF) comparing closure of the LAA* (with the Watchman occluder) with long-term warfarin therapy <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/protectaffinal-120727133352-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds" /> http://www.theheart.org/web_slides/1146285.do A prospective randomized trial on Embolic Protection in Patients with Atrial Fibrillation (PROTECT-AF) comparing closure of the LAA* (with the Watchman occluder) with long-term warfarin therapy

PROTECT-AF trial - Summary & Results from theheart.org

]]> 1130 7 https://cdn.slidesharecdn.com/ss_thumbnails/protectaffinal-120727133352-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation White http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

1 PRELUDE trial - Summary & Results /slideshow/prelude-13779067/13779067 preludefinal-120727124027-phpapp01
http://www.theheart.org/web_slides/1242353.do An analysis based on an Italian registry of 308 patients with Brugada syndrome who underwent programmed electrical stimulation (PES) studies according to one consistent protocol (unlike earlier multicenter studies that were based on varying PES protocols) ]]>
http://www.theheart.org/web_slides/1242353.do An analysis based on an Italian registry of 308 patients with Brugada syndrome who underwent programmed electrical stimulation (PES) studies according to one consistent protocol (unlike earlier multicenter studies that were based on varying PES protocols) ]]> Fri, 27 Jul 2012 12:40:24 GMT /slideshow/prelude-13779067/13779067 theheartorg@slideshare.net(theheartorg) PRELUDE trial - Summary & Results theheartorg http://www.theheart.org/web_slides/1242353.do An analysis based on an Italian registry of 308 patients with Brugada syndrome who underwent programmed electrical stimulation (PES) studies according to one consistent protocol (unlike earlier multicenter studies that were based on varying PES protocols) <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/preludefinal-120727124027-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds" /> http://www.theheart.org/web_slides/1242353.do An analysis based on an Italian registry of 308 patients with Brugada syndrome who underwent programmed electrical stimulation (PES) studies according to one consistent protocol (unlike earlier multicenter studies that were based on varying PES protocols)

PRELUDE trial - Summary & Results from theheart.org

]]> 371 5 https://cdn.slidesharecdn.com/ss_thumbnails/preludefinal-120727124027-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds presentation White http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

1 ALTITUDE trial - Summary & Results /slideshow/altitude-13779060/13779060 altitudefinal-120727123933-phpapp02
http://www.theheart.org/web_slides/1242347.do A trial on ALTITUDE to evaluate mortality after device implantation or after shock therapy in large numbers of patients with implanted devices]]>
http://www.theheart.org/web_slides/1242347.do A trial on ALTITUDE to evaluate mortality after device implantation or after shock therapy in large numbers of patients with implanted devices]]> Fri, 27 Jul 2012 12:39:32 GMT /slideshow/altitude-13779060/13779060 theheartorg@slideshare.net(theheartorg) ALTITUDE trial - Summary & Results theheartorg http://www.theheart.org/web_slides/1242347.do A trial on ALTITUDE to evaluate mortality after device implantation or after shock therapy in large numbers of patients with implanted devices <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/altitudefinal-120727123933-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds" /> http://www.theheart.org/web_slides/1242347.do A trial on ALTITUDE to evaluate mortality after device implantation or after shock therapy in large numbers of patients with implanted devices

ALTITUDE trial - Summary & Results from theheart.org

]]> 575 2 https://cdn.slidesharecdn.com/ss_thumbnails/altitudefinal-120727123933-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation White http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

1 https://cdn.slidesharecdn.com/profile-photo-theheartorg-48x48.jpg?cb=1523102050 theheart.org is a leader in independent cardiology news, opinions, and educational programming for cardiologists and healthcare professionals. www.theheart.org https://cdn.slidesharecdn.com/ss_thumbnails/tct2012-121207065911-phpapp02-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/tct-2012-research-highlights-a-slideshow-presentation/15534342 TCT 2012 research high... https://cdn.slidesharecdn.com/ss_thumbnails/esc2012-121207065209-phpapp02-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/esc-2012-research-highlights-a-slideshow-presentation/15534250 ESC 2012 research high... https://cdn.slidesharecdn.com/ss_thumbnails/aha2012-121122084556-phpapp01-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/aha-2012-research-highlights/15299237 AHA 2012 Research High...